Emmanuelle Duron

Emmanuelle Duron

Auto-generated profile, based on publicly available information

Emmanuelle Duron

AP-HP, Hôpital Broca, Service de Gériatrie, Paris, France

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
SMShima Mehrabian
Shima Mehrabian
EDEmmanuelle Duron
Emmanuelle Duron
FLFlorian Labouree
Florian Labouree
FRFlorence Rollot
Florence Rollot
ABAlex Bune
Alex Bune
OHOlivier Hanon
Olivier Hanon

1 August 2011 in Annals of Surgery
Verified
Journal Article
Closed access
JDJean-Jacques Duron
Jean-Jacques Duron
EDEmmanuelle Duron
Emmanuelle Duron
TDThimothée Dugue
Thimothée Dugue
JPJosé Pujol
José Pujol
FMFabrice Muscari
Fabrice Muscari
JHJean-Marie Hay
Jean-Marie Hay
To identify the mortality risk factors of elderly patients (≥65 years old) during major digestive surgery, as defined according to the complexity of the operation. In the aging populations of developed countries, the incidence rate of major digestive surgery is currently on the rise and is associated with a high mortality rate. Consequently, validated indicators must be developed to improve elderly patients' surgical care and outcomes. We acquired data from a multicenter prospective cohort that included 3322 consecutive patients undergoing major digestive surgery across 47 different facilities. We assessed 27 pre-, intra-, and postoperative demographic and clinical variables. A multivariate analysis was used to identify the independent risk factors of mortality in elderly patients (n = 1796). Young patients were used as a control group, and the end-point was defined as 30-day postoperative mortality. In the entire cohort, postoperative mortality increased significantly among patients aged 65-74 years, and an age ≥65 years was by itself an independent risk factor for mortality (odds ratio [OR], 2.21; 95% confidence interval [CI], 1.36-3.59; P = 0.001). The mortality rate among elderly patients was 10.6%. Six independent risk factors of mortality were characteristic of the elderly patients: age ≥85 years (OR, 2.62; 95% CI, 1.08-6.31; P = 0.032), emergency (OR, 3.42; 95% CI, 1.67-6.99; P = 0.001), anemia (OR, 1.80; 95% CI, 1.02-3.17; P = 0.041), white cell count > 10,000/mm³ (OR, 1.90; 95% CI, 1.08-3.35; P = 0.024), ASA class IV (OR, 9.86; 95% CI, 1.77-54.7; P = 0.009) and a palliative cancer operation (OR, 4.03; 95% CI, 1.99-8.19; P < 0.001). Characterization of independent validated risk indicators for mortality in elderly patients undergoing major digestive surgery is essential and may lead to an efficient specific workup, which constitutes a necessary step to developing a dedicated score for elderly patients.

1 March 2008 in Archives of Cardiovascular Diseases
Verified
Journal Article
Closed access
EDE. Duron
E. Duron
OHO. Hanon
O. Hanon

1 December 2012 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
EDEmmanuelle Duron
Emmanuelle Duron
BFBenoît Funalot
Benoît Funalot
NBNadège Brunel
Nadège Brunel
JCJoel Coste
Joel Coste
LQLaurent Quinquis
Laurent Quinquis
OHOlivier Hanon
Olivier Hanon
Context: Few large studies have been conducted to assess the relationship between circulating IGF and late-life cognition. Objective: The aim of the study was to assess the relationship between IGF-I and IGF binding protein-3 (IGFBP-3) serum levels and cognitive impairment, including Alzheimer's disease (AD). Methods: In this multicentric cross-sectional study, 694 elderly subjects (218 men, 476 women; 78.6 ± 6.7 yr old) were included; 481 had memory complaints and were diagnosed, after comprehensive cognitive assessment, with AD (n = 224) or mild cognitive impairment (MCI) (n = 257). The control group was comprised of 213 subjects without memory complaint and with normal cognition (recruited among patients' caregivers). IGF-I and IGFBP-3 serum levels were determined by ELISA. Results: IGF-I and IGFBP-3 serum levels were significantly associated with cognitive status in men (IGF-I, 137 ± 69 ng/ml for AD vs. 178 ± 88 ng/ml for MCI and 172 ± 91 ng/ml for controls, P = 0.01; IGFBP-3, 3675 ± 1542 ng/ml for AD vs. 4143 ± 1828 ng/ml for MCI and 4488 ± 1893 ng/ml for controls, P = 0.04). In women, IGFBP-3 was significantly associated with cognitive status (3781 ± 1351 ng/ml for AD vs. 4190 ± 1408 ng/ml for MCI and 4390 ± 1552 ng/ml for controls; P < 0.001), but no significant differences between groups for IGF-I occurred. After adjustment for confounding variables (age, educational level, body mass index, diabetes, apolipoprotein E ε4 status), logistic regression indicated that IGF-I [odds ratio (95% confidence interval) = 0.48 (0.26–0.88)] and IGFBP-3 [odds ratio (95% confidence interval) = 0.71 (0.52–0.97)] serum levels were independently associated with AD in men, but not in women. Conclusions: We report a significant association between low IGF-I and IGFBP-3 serum levels and AD in men, but not in women.

1 October 2009 in Progress in Neurobiology
Verified
Journal Article
Closed access
JEJacques Epelbaum
Jacques Epelbaum
JGJean-Louis Guillou
Jean-Louis Guillou
FGFrançois Gastambide
François Gastambide
DHDaniel Hoyer
Daniel Hoyer
EDEmmanuelle Duron
Emmanuelle Duron
CVCécile Viollet
Cécile Viollet

1 April 2010 in Radiology
Verified
Journal Article
Closed access
SDSophie Dupont
Sophie Dupont
EDEmmanuelle Duron
Emmanuelle Duron
SSSéverine Samson
Séverine Samson
MDMarisa Denos
Marisa Denos
EVEmmanuelle Volle
Emmanuelle Volle
MBMichel Baulac
Michel Baulac
To retrospectively determine whether blood oxygen level-dependent functional magnetic resonance (MR) imaging can aid prediction of postoperative memory changes in epileptic patients after temporal lobe surgery. This study was approved by the local ethics committee, and informed consent was obtained from all patients. Data were analyzed from 25 patients (12 women, 13 men; age range, 19-52 years) with refractory epilepsy in whom temporal lobe surgery was performed after they underwent preoperative functional MR imaging, the Wada test, and neuropsychological testing. The functional MR imaging protocol included three different memory tasks (24-hour delayed recognition, encoding, and immediate recognition). Individual activations were measured in medial temporal lobe (MTL) regions of both hemispheres. The prognostic accuracy of functional MR imaging for prediction of postoperative memory changes was compared with the accuracy of the Wada test and preoperative neuropsychological testing by using a backward multiple regression analysis. An equation that was based on left functional MR imaging MTL activation during delayed recognition, side of the epileptic focus, and preoperative global verbal memory score was used to correctly predict worsening of verbal memory in 90% of patients. The right functional MR imaging MTL activation did not substantially correlate with the nonverbal memory outcome, which was only predicted by using the preoperative nonverbal global score. Wada test data were not good predictors of changes in either verbal or nonverbal memory. Findings suggest that functional MR imaging activation during a delayed-recognition task is a better predictor of individual postoperative verbal memory outcome than is the Wada test.